MCR Labs in Framingham has completed upgrades to their facility and procedures in order to resume allowing medical cannabis home growers to safely visit their offices and submit sample testing.
The state restricted access during the pandemic for the last several months because of COVID-19.
“We can only accept samples here at our office since it is not federally legal to ship cannabis,” said Michael Kahn, MCR Labs President. “Many of our clients--our friends--are battling illnesses that put them at greater risk, we decided it best to pause and implement changes that minimize any potential risk for those who rely on us to confirm their cannabis is safe.”
Prior to the shutdown in March, MCR Labs processed an average of 413 samples per month for their clients.
In preparation for fully reopening, the organization has taken the several actions to ensure safety at their Framingham facility.
Sample submission will be by appointment-only to limit on-site traffic. The installation of UV lights are HEPA air filters to eliminate surface and airborne pathogens.
The reception desk is now equipped with barriers and safety glass for contact-free sample submission. The staff will receive a health screening with temperature checks as well as masks being required for all staff and visitors.
“Public safety is always our primary focus, and we rely on science to achieve that,” said Scott Churchill, MCR Labs Director of Scientific Operations.“We looked at evidence-based ways to prevent COVID exposure and went above and beyond to create the safest environment possible for all of our clients.”
Patients, caregivers and home growers can now set up an appointment to submit samples by visiting http://mcrlabs.com or by calling their office at (508) 872-6666 from 10 a.m. to 5 p.m. on weekdays.